Today: 21 July 2026
Exxon Mobil stock price today: XOM rises as oil hovers near six-month highs and Supreme Court cases draw focus
23 February 2026
1 min read

Exxon Mobil stock price today: XOM rises as oil hovers near six-month highs and Supreme Court cases draw focus

New York, Feb 23, 2026, 13:50 EST — Regular session

Exxon Mobil Corp climbed 2.2% to $150.47 on Monday afternoon, outperforming much of the U.S. market as energy names got some traction. Shares ranged from $146.56 to $151.24. The S&P 500 ETF slipped around 0.8%, while a broad energy ETF managed a small gain.

Energy remains a rare spot where investors keep finding steady cash flow, dodging the noisy tariff and growth stories playing out in other sectors. For Exxon, with its reach across crude production, refining, and chemicals, oil’s daily price swings keep driving the mood.

Oil slipped, holding close to six-month highs. Brent crude shed 0.52% to trade at $71.39 a barrel, while U.S. West Texas Intermediate (WTI) edged 0.41% lower to $66.21 as of 12:44 p.m. ET. Traders tracked heightened U.S.-Iran friction and renewed trade-policy jitters. “That seemed to suggest that they are more open to talking about their nuclear program,” said Phil Flynn, analyst at Price Futures Group. Reuters

Exxon found itself in the Washington spotlight for legal reasons. The U.S. Supreme Court said it would take up a request from Exxon and Suncor Energy to dismiss Boulder, Colorado’s climate case—a lawsuit that could set the tone for many others brought by states and cities.

The court will also take up Exxon’s Helms-Burton suit, where the company is pursuing upwards of $1 billion from Cuban state-owned firms over property seized back in 1960. At the core: whether U.S. courts have the reach in expropriation battles like this, and how “foreign sovereign immunity”—the legal doctrine shielding foreign governments from lawsuits—should apply here. The case hinges on whether any exception to that immunity kicks in. Reuters

Chevron ticked up roughly 0.5%, with BP ahead by around 0.4%. U.S.-listed Shell added about 0.3% as oil majors moved higher.

Goldman Sachs bumped up its Q4 2026 oil price outlook, but left its estimate for a 2.3 million barrels per day surplus in 2026 unchanged. The bank also said it sees OPEC+ beginning to lift production slowly in the second quarter.

Crude’s bounce is worming its way back into inflation calculations. Gregory Daco, chief economist at EY-Parthenon, puts it this way: a $10 bump in oil, if it sticks, could nudge U.S. annual inflation higher by as much as 0.2 percentage point. That’s with “base effects” losing their grip—those easy year-on-year comparisons are fading, and energy’s drag on inflation is slipping out of the picture. Reuters

Still, energy stocks aren’t insulated. If the geopolitical premium fades quickly—or worries over growth suddenly hit fuel demand forecasts—crude could tumble, taking the sector down with it.

The next potential mover for traders lands Thursday, Feb. 26, with Oman confirming that U.S.-Iran talks are scheduled in Geneva. Anything that nudges the outlook on sanctions or supply risk could quickly sway oil prices—and XOM—through week’s end.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • SpaceX Shares Dip Under IPO Mark, Raising Contrarian Interest
    July 21, 2026, 10:16 AM EDT. SpaceX (NASDAQ: SPCX) has fallen below its IPO mark of $135, trading near $124 after a 45% retreat from a $226 high. This slide appears tied to hype correction rather than underlying business weakness. With Starlink now counting 10 million subscribers and Deutsche Bank issuing a buy rating and $255 price target, the company stands valued at $1.64 trillion and trades at 84 times sales, maintaining a profile that is both highly speculative and high-conviction.
Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week
Previous Story

Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop